Home
Contact Careers rss
 
The Road to Prevention

The Global HIV Vaccine Enterprise (the Enterprise) is a unique global alliance of independent organizations working together to accelerate the development of safe and effective HIV vaccines. The cornerstone of the Enterprise is its Scientific Strategic Plan (the Plan), the framework for a new era of HIV vaccine research that builds on the exceptional progress from the past five years. Developed by the Enterprise Council with the input of more than 400 researchers, policy-makers, funders and advocates worldwide, the 2010 Plan will be released at the AIDS Vaccine 2010 conference in Atlanta, USA in September. In advance of the 2010 Plan, the Enterprise released a new overview of the greatest challenges and opportunities in HIV vaccine research at AIDS 2010 in Vienna.

AIDS Vaccine Conference 2010 Logo

Special Report - RV144



Working Group 1 - Immunogens and Antigen Processing Working Group 2 - Host Genetics and HIV Diversity Working Group 3 - Novel Approaches to HIV Vaccine Research and Development Working Group 4 - Bridging The Gaps Working Group 5 - Young & Early Career Investigators (YECI)
HISTORY of the SCIENTIFIC STRATEGIC PLAN
In the February 2005 issue of Public Library of Science (PLoS) - Medicine, the Enterprise published a scientific strategic plan for accelerating HIV vaccine research. The Plan described the major challenges facing the field at that time and made recommendations in six priority areas: History of the Plan
  • Vaccine discovery
  • Laboratory standardization
  • Product development & manufacturing
  • Clinical trials capacity
  • Intellectual property issues
  • Regulatory considerations
The 2005 Plan catalyzed major, new activities and funding commitments of a number of government and non-government organizations. It also led to the creation of new research structures and new ways of collaborating on a global scale.

Learn More..
STAKEHOLDER ORGANIZATIONS

The Enterprise is a unique alliance of organizations that has the convening power to bring together an inclusive global alliance of top researchers, funders, advocacy groups, and stakeholders to catalyze fresh thinking, set new directions and advance global cooperation to develop an HIV vaccine.
Follow Us:
Follow us on Facebook     Follow us on Twitter     Follow us using LinkedIn

Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2010 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account